ThetaRay and Spayce Partner to Combat Financial Crime and Secure Global Payments with Cognitive AI
3.6.2025 06:00:00 CEST | Business Wire | Press release
Unveiled at Money 20/20, the partnership combines ThetaRay’s advanced Cognitive AI with Spayce’s cross-border payment technology to detect financial crime, enhance compliance, and protect global transactions.
ThetaRay, a global leader in Cognitive AI financial crime compliance, and Spayce, a cross-border payments platform, today announced a strategic partnership to combat evolving financial threats and enhance global payment security. The collaboration will be officially unveiled at Money 20/20.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250602138235/en/
The announcement comes at a time when the financial crime landscape is undergoing a dramatic transformation. As criminal networks grow more sophisticated and agile, operating with the complexity of multinational corporations, traditional rule-based anti-money laundering (AML) systems are increasingly outpaced. These outdated tools often miss hidden threats, allowing illicit activity to slip through undetected and exposing institutions to regulatory, financial, and reputational risk.
Spayce has deployed ThetaRay’s Cognitive AI Transaction Monitoring solution into its global payments infrastructure to enhance its financial crime detection capabilities. ThetaRay’s solution uses Cognitive AI to continuously analyze the vast volumes of transaction data, detecting nuanced suspicious activity, and uncovering complex financial crime schemes with exceptional accuracy. This AI-first approach not only strengthens compliance but empowers Spayce to scale securely, turning regulatory readiness into a foundation for sustainable growth.
Spayce, which serves clients ranging from SMBs to large financial institutions in over 200 countries, now gains deeper visibility into transaction flows without compromising speed or customer experience. The result is a smarter, faster, and more secure global payments ecosystem, one where compliance no longer slows expansion, but actively enables it.
“Financial crime is evolving rapidly, and the technology used to combat it must evolve even faster,” said Peter Reynolds, CEO of ThetaRay. “Our partnership with Spayce unites robust payment infrastructure with ThetaRay’s Cognitive AI to deliver proactive risk mitigation, greater transparency, and the trusted cross-border transactions needed to power global growth.”
“As Spayce expands its global payments capabilities, security and AML compliance remain at the core of our mission,” said Debra LePage, Partner & Co-Founder of Spayce. “Partnering with ThetaRay empowers us to stay ahead of increasingly sophisticated financial threats, while continuing to deliver seamless, trusted payment experiences for our customers worldwide.”
About ThetaRay
ThetaRay harnesses the power of Cognitive AI for financial crime compliance, enabling financial institutions to precisely identify legitimate customers while flagging bad actors. The SaaS solutions overcome the limitations of traditional rule-based systems by shortening long implementation lifecycles, enabling efficient, risk-aware compliance operations. By transforming compliance from a regulatory obligation into a driver of growth, ThetaRay allows institutions to scale faster and expand confidently into new markets. By uncovering hidden criminal networks and delivering actionable insights, ThetaRay empowers organizations to combat evolving threats, maintain positive regulator relationships, and enhance customer experiences. Implemented at some of the world’s leading financial institutions including Santander, Clear Bank, Mashreq Bank, Payoneer, Onafriq and Travelex, ThetaRay helps financial institutions thrive, fostering trust and confidence across the global financial ecosystem.
About Spayce
Spayce is a next-generation cross-border payment platform enabling seamless, secure, and scalable global transactions. With over three decades of experience in the payments and financial technology industry, Spayce is the trusted payments technology partner that businesses rely on to move their money securely and efficiently domestically and across borders.
Built by industry veterans, Spayce supports a wide range of use cases—including vendor payouts, global payroll, eCommerce settlements, and real-time B2P and B2B payments—through powerful APIs, a hosted checkout solution, and an intuitive merchant portal.
Through their trusted network of global banking partners, Spayce delivers speed, transparency, and compliance at scale; with a deep commitment to financial crime prevention and regulatory excellence, Spayce enables clients to grow globally with confidence while maintaining the highest standards of trust and security. Operating in over 200 countries and territories, Spayce combines cutting-edge technology with deep regulatory and operational expertise to deliver frictionless payment experiences.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250602138235/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release
Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release
Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom